Risk of Malignancy Index (RMI-2) in the Evaluation of Adenexal Masses

Authors

  • Mahajan G1 , Bhatia R2, Kaura M3 , Kaur P4 , Kaur M5

DOI:

https://doi.org/10.37506/ijphrd.v11i8.10898

Keywords:

RMI-2,Ovarian malignancy,CA-125,U-Score,Menopausal

Abstract

The present prospective study, conducted in the department of Obstetrics and Gynaecology and department

of Biochemistry, Government Medical College and Rajindra Hospital,Patiala . Fifty patients after taking

a detailed history and examination underwent various investigations including CA-125 levels and

ultrasonography. RMI-2 was calculated for each patient preoperatively and later compared with respective

histopathological examination. The present study demonstrated that RMI-2 (at a cut-off value of 200) is a

screening method with high sensitivity and specificity in predicting benign or malignant nature of adenexal

masses. It is a simple, easy and useful method to apply in a tertiary care hospital. Our study reconfirms

accuracy of RMI in diagnosing adenexal masses with high risk of malignancy. Small sample size, more

number of pre-menopausal and more number of benign ovarian masses were some of the limitations of

present study.

Author Biography

  • Mahajan G1 , Bhatia R2, Kaura M3 , Kaur P4 , Kaur M5

    1 Senior Resident, Hindurao hospital and medical college, New Delhi, ex-junior resident, GMC Patiala,

    2 Prof and HOD, Dept. of OBG, MMIMSR, MMU Deemed to be university, Mullana. Ex-Professor, Dept of OBG,

    GMC Patiala, 3Junior resident, Dept of OBG, MMIMSR Mullana, 4 Ex-Professor, Dept of OBG, GMC Patiala, 5

    Prof., Dept of Biochemistry, GMC, Rajindra hospital, Patiala

Downloads

Published

2020-08-31

How to Cite

Risk of Malignancy Index (RMI-2) in the Evaluation of Adenexal Masses. (2020). Indian Journal of Public Health Research & Development, 11(8), 64-70. https://doi.org/10.37506/ijphrd.v11i8.10898